A. Santamato, “Effectiveness of Switching Therapy from Complexing Protein-containing Botulinum Toxin Type A to a Formulation with Low Immunogenicity in Spasticity after Stroke: A case report”, JRM, vol. 44, no. 9, pp. 795–797, Jun. 2012.